An honest read
of the autism evidence.
HBOT is not a cure for autism. It is an off-label, evidence-supported indication recognized by the International Hyperbarics Association, with a real but uneven published response signal. This page explains what the literature shows, what protocol is used, and the clinical protections in place for every pediatric course we run.
Why HBOT plausibly helps a subset of children.
Cerebral perfusion & neuroinflammation
SPECT and functional MRI studies in autistic children consistently show regions of hypoperfusion in the temporal lobes and limbic structures. HBOT increases dissolved oxygen delivery to under-perfused tissue and downregulates pro-inflammatory cytokines (TNF-α, IL-6) that are elevated in a meaningful subset of children with ASD.
Mitochondrial function
A subset of children with ASD show markers of mitochondrial dysfunction. HBOT has been shown to improve mitochondrial efficiency and reduce oxidative stress — a plausible mechanism for the energy, sleep, and cognitive gains some families report.
Gastrointestinal & immune modulation
GI inflammation is over-represented in ASD. HBOT reduces systemic inflammatory load and supports gut-barrier integrity. Parents who report digestive improvement during a course tend to also report better sleep and attention.
Sensory, attention, social engagement
Across trials and case series, the most consistently reported behavioral changes are improved sleep, increased eye contact, longer attention span, and reduced sensory reactivity. Effect sizes vary; response is not universal.
How we run a pediatric course responsibly.
Physician review before booking
No pediatric chamber session is scheduled until a consulting physician — coordinated via the IHA Physician Advisory Board — has reviewed the case file, current medications, ear-clearing capacity, and seizure history.
o2providers.com screening
Every pediatric client is screened through the same clinical pathway used by IHA-affiliated clinics — the infrastructure built and maintained by Dr. Zayd Ratansi's training network.
20-session evaluation block
We do not sell a full 40-session course up front. Families purchase a 20-session evaluation. If no measurable change is observed, the course stops and the unused balance is refunded.
1.3 ATA default protocol
The pediatric default is the 1.3 ATA, 60-minute protocol used in Rossignol 2009. Higher pressures are used only with direct clinician supervision and a specific clinical rationale.
Transparent on what we don't know
Response is not universal. We do not show cherry-picked testimonials, do not guarantee outcomes, and do not market to families in active crisis.
IHA indication framework alignment
Our clinical framing follows the International Hyperbarics Association autism indication guidance — the same framework taught through IBUM certification.
What to expect.
Will my child respond?
Honestly: we don't know in advance. The literature suggests children with documented neuroinflammation, GI symptoms, or mitochondrial markers respond more often than children without those features. Our physician reviews each case before recommending a trial course.
What is the minimum trial?
We recommend a 20-session evaluation block. If clear changes in sleep, attention, language, or behavior are observed at the 20-session mark, we continue to the 40-session course used in the published trials. If no signal is observed, we stop and refund the unused balance.
Is HBOT safe for children?
When delivered at 1.3 ATA in a properly maintained chamber with trained operators and pre-screening, the pediatric safety profile is well established. The main risks are ear barotrauma (preventable with screening and equalization training) and, very rarely, oxygen-related effects at higher pressures. We use 1.3 ATA as the default pediatric protocol.
Who supervises my child's course?
Every pediatric course is reviewed by a consulting physician before the first session, again at 20 sessions, and again at completion. Daily operations are run by IBUM-certified technicians trained on the o2providers.com platform — the same clinical infrastructure used by IHA member clinics.
Is this covered by insurance?
Generally no. HBOT for autism is off-label and almost universally not covered by commercial insurance or Medicaid. We are transparent about pricing and do not encourage families to take on debt for an off-label trial.
Selected peer-reviewed studies.
Includes the most-cited null-result trial. We show the full evidence picture, not a curated subset.
Other conditions studied with HBOT.
Anti-aging & cellular renewal
Read the mechanism, the published protocol, and linked PubMed citations.
Alzheimer's & dementia
Read the mechanism, the published protocol, and linked PubMed citations.
Addiction & recovery
Read the mechanism, the published protocol, and linked PubMed citations.
Start with a physician consult.
No pediatric chamber sessions are booked before clinician review. Begin with a 30-minute case-file consultation, coordinated via the IHA Physician Advisory Board.